152 related articles for article (PubMed ID: 29369166)
1. Novel mediators of statin effects on plaque in HIV: a proteomics approach.
deFilippi C; Lo J; Christenson R; Grundberg I; Stone L; Zanni MV; Lee H; Grinspoon SK
AIDS; 2018 Apr; 32(7):867-876. PubMed ID: 29369166
[TBL] [Abstract][Full Text] [Related]
2. Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.
Nou E; Lu MT; Looby SE; Fitch KV; Kim EA; Lee H; Hoffmann U; Grinspoon SK; Lo J
AIDS; 2016 Feb; 30(4):583-90. PubMed ID: 26558731
[TBL] [Abstract][Full Text] [Related]
3. Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
Lo J; Lu MT; Ihenachor EJ; Wei J; Looby SE; Fitch KV; Oh J; Zimmerman CO; Hwang J; Abbara S; Plutzky J; Robbins G; Tawakol A; Hoffmann U; Grinspoon SK
Lancet HIV; 2015 Feb; 2(2):e52-63. PubMed ID: 26424461
[TBL] [Abstract][Full Text] [Related]
4. Individual coronary plaque changes on serial CT angiography: Within-patient heterogeneity, natural history, and statin effects in HIV.
Foldyna B; Lo J; Mayrhofer T; Grinspoon SK; Hoffmann U; Lu MT
J Cardiovasc Comput Tomogr; 2020; 14(2):144-148. PubMed ID: 31451438
[TBL] [Abstract][Full Text] [Related]
5. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
[TBL] [Abstract][Full Text] [Related]
6. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
[TBL] [Abstract][Full Text] [Related]
7. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular computed tomographic assessment of the effect of combination lipoprotein therapy on coronary arterial plaque: rationale and design of the AFRICA (Atorvastatin plus Fenofibric acid in the Reduction of Intermediate Coronary Atherosclerosis) study.
Voros S; Joshi PH; Vazquez G; Roth G; Murrieta L; Rinehart S; Qian Z; Miller J
J Cardiovasc Comput Tomogr; 2010; 4(3):164-72. PubMed ID: 20413364
[TBL] [Abstract][Full Text] [Related]
9. Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.
Fitch KV; DeFilippi C; Christenson R; Srinivasa S; Lee H; Lo J; Lu MT; Wong K; Petrow E; Sanchez L; Looby SE; Hoffmann U; Zanni M; Grinspoon SK
AIDS; 2016 Sep; 30(14):2205-14. PubMed ID: 27314177
[TBL] [Abstract][Full Text] [Related]
10. [Effects of statin intervention on mild coronary plaque progression assessed by serial coronary CT angiography].
Li ZN; Hou ZH; Liu K; Wang ZQ; Yin WH; Gao Y; Xu HY; Jiang SL; Lyu B
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jun; 44(6):508-12. PubMed ID: 27346264
[TBL] [Abstract][Full Text] [Related]
11. Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV).
Puri R; Nissen SE; Somaratne R; Cho L; Kastelein JJ; Ballantyne CM; Koenig W; Anderson TJ; Yang J; Kassahun H; Wasserman SM; Scott R; Borgman M; Nicholls SJ
Am Heart J; 2016 Jun; 176():83-92. PubMed ID: 27264224
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of ezetimibe addition on coronary atheroma regression in patients with prior statin therapy: Subanalysis of PRECISE-IVUS trial.
Tsujita K; Yamanaga K; Komura N; Sakamoto K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
Eur J Prev Cardiol; 2016 Sep; 23(14):1524-8. PubMed ID: 27296705
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease.
Suzuki T; Nozawa T; Fujii N; Sobajima M; Ohori T; Shida T; Matsuki A; Kameyama T; Inoue H
Coron Artery Dis; 2011 Aug; 22(5):352-8. PubMed ID: 21494127
[TBL] [Abstract][Full Text] [Related]
14. Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
Alfaddagh A; Elajami TK; Ashfaque H; Saleh M; Bistrian BR; Welty FK
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246960
[TBL] [Abstract][Full Text] [Related]
15. Virtual histology findings and effects of varying doses of atorvastatin on coronary plaque volume and composition in statin-naive patients: the VENUS study.
Lee SW; Hau WK; Kong SL; Chan KK; Chan PH; Lam SC; Tam FC; Wong MK; Chan CW; Lam YM; Tse HF; Chan RH
Circ J; 2012; 76(11):2662-72. PubMed ID: 22864277
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study.
Hiro T; Hirayama A; Ueda Y; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K;
J Cardiol; 2014 Dec; 64(6):501-7. PubMed ID: 24725763
[TBL] [Abstract][Full Text] [Related]
17. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial.
Schmermund A; Achenbach S; Budde T; Buziashvili Y; Förster A; Friedrich G; Henein M; Kerkhoff G; Knollmann F; Kukharchuk V; Lahiri A; Leischik R; Moshage W; Schartl M; Siffert W; Steinhagen-Thiessen E; Sinitsyn V; Vogt A; Wiedeking B; Erbel R
Circulation; 2006 Jan; 113(3):427-37. PubMed ID: 16415377
[TBL] [Abstract][Full Text] [Related]
18. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
Circ J; 2011; 75(2):398-406. PubMed ID: 21157106
[TBL] [Abstract][Full Text] [Related]
19. Effect of two intensive statin regimens on progression of coronary disease.
Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
[TBL] [Abstract][Full Text] [Related]
20. Is age an important factor for vascular response to statin therapy? A serial optical coherence tomography and intravascular ultrasound study.
Dai J; Hou J; Xing L; Jia H; Hu S; Soeda T; Minami Y; Ong D; Vergallo R; Zhang S; Lee H; Yu B; Jang IK
Coron Artery Dis; 2017 May; 28(3):209-217. PubMed ID: 28059849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
